Mechanisms of the prostaglandin F2α-induced rise in [Ca2+]i in rat intrapulmonary arteries

Journal of Physiology

Volumn 571, Issue 1, 2006, Pages 147-163

  Snetkov, Vladimir A ^a   Knock, Gregory A ^a   Baxter, Lynne ^a   Thomas, Gavin D ^a   Ward, Jeremy P T ^a   Aaronson, Philip I ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BALANCED SALT SOLUTION; CALCIUM; CALCIUM CHANNEL L TYPE; DILTIAZEM; FLUPROSTENOL; PHOSPHOLIPASE C; PROSTAGLANDIN F2 ALPHA; STRONTIUM; THAPSIGARGIN; 2 AMINOETHOXYDIPHENYLBORANE; 2-AMINOETHOXYDIPHENYL BORATE; BORON DERIVATIVE; CARDIOVASCULAR AGENT; INOSITOL 1,4,5 TRISPHOSPHATE; PROSTAGLANDIN F2ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; THROMBOXANE RECEPTOR; VASOCONSTRICTOR AGENT; LANTHANUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL PERMEABILITY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY ARTERY OCCLUSION; RAT; RAT STRAIN; STUDENT T TEST; ANIMAL; CHEMISTRY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WISTAR RAT;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BORON COMPOUNDS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CARDIOVASCULAR AGENTS; DILTIAZEM; DINOPROST; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; MUSCLE, SMOOTH, VASCULAR; PHOSPHOLIPASE C; PULMONARY ARTERY; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33645852254     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.101394     Document Type: Article

References (51)

1. Aaronson PI, Robertson TP, Knock GA, Becker S, Snetkov V & Ward JPT (2006). Hypoxic pulmonary vasoconstriction: Mechanisms and controversies. Journal of Physiology 570, 53-58.
2. Abrenica B, Pierce GN & Gilchrist JSC (2003). Nucleoplasmic calcium regulation in rabbit aortic vascular smooth muscle cells. Can J Physiol Pharmacol 81, 301-310.
3. 2+ -permeable non-selective cation channels in smooth muscle cells. Cell Calcium 33, 345-356.
4. 2+ measured with Fura-2. Br J Pharmacol 104, 373-378.
5. Boersma JI, Janzen KM, Oliveira L & Crankshaw DJ (1999). Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br J Pharmacol 128, 1505-1512.
6. Bradley AB & Morgan KG (1987). Alterations in cytoplasmic calcium sensitivity during porcine coronary artery contractions as detected by aequorin. J Physiol 385, 437-448.
7. Breyer RM, Bagdassarian CK, Myers SA & Breyer MD (2001). Prostanoid receptors: Subtypes and signaling. Annu Rev Pharmacol Toxicol 41, 661-690.
8. 2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin. J Physiol 517, 121-134.
9. 2+ efflux in A7r5 rat smooth muscle cells. J Physiol 485, 455-468.
10. + channels and pulmonary vasoconstriction: Role of protein kinase C ζ. Circ Res 93, 656-663.
11. Daray FM, Minvielle AI, Puppo S & Rothlin RP (2003). Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein. Br J Pharmacol 139, 1409-1416.
12. Ding X & Murray PA (2005). Cellular mechanisms of thromboxane A2-mediated contraction in pulmonary veins. Am J Physiol 289, L825-L833.
13. Dorn GW, Becker MW & Davis MG (1992). Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem 267, 24897-24905.
14. A receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: A tyrosine kinase independent pathway. Br J Pharmacol 127, 153-160.
15. Flemming R, Cheong A, Dedman AM & Beech DJ (2002). Discrete store-operated calcium influx into an intracellular compartment in rabbit arteriolar smooth muscle. J Physiol 543, 455-464.
16. 2+ entry channels involved in contractions of rat aorta induced by endothelin-1, noradrenaline, and vasopressin. J Cardiovasc Pharmacol 40, 265-276.
17. Goff CD, Corbin RS, Theiss SD, Frierson HF Jr, Cephas GA, Tribble CG, Kron IL & Young JS (1997). Postinjury thromboxane receptor blockade ameliorates acute lung injury. Ann Thorac Surg 64, 826-829.
18. 2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol 280, H746-H755.
19. 2+ sparks in vascular myocytes. Cell Calcium 29, 13-28.
20. Guibert C, Marthan R & Savineau JP (2004). 5-HT induces an arachidonic acid-sensitive calcium influx in rat small intrapulmonary artery. Am J Physiol 286, L1228-L1236.
21. Hansen M, Boitano S, Dirksen ER & Sanderson MJ (1995). A role for phospholipase C activity but not ryanodine receptors in the initiation and propagation of intercellular calcium waves. J Cell Sci 108, 2583-2590.
22. Helliwell RM & Large WA (1997). Alpha 1-adrenoceptor activation of a non-selective cation current in rabbit portal vein by 1,2-diacyl-sn -glycerol. J Physiol 499, 417-428.
23. 2+ sensitivity in rabbit pulmonary artery smooth muscle. Pflugers Arch 417, 21-28.
24. 2+ level with Fura-2. Br J Pharmacol 100, 677-684.
25. Hori M, Sato K, Sakata K, Ozaki H, Takano-Ohmuro H, Tsuchiya T, Sugi H, Kato I & Karaki H (1992). Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle. J Pharmacol Exp Ther 261, 506-512.
26. Horiuti K (1986). Some properties of the contractile system and sarcoplasmic reticulum of skinned slow fibres from Xenopus muscle. J Physiol 373, 1-23.
27. Hyvelin JM, O'Connor C & McLoughlin P (2004). Effect of changes in pH on wall tension in isolated rat pulmonary artery: Role of the RhoA/ Rho-kinase pathway. Am J Physiol 287, L673-L684.
28. 2+-permeable cation channel. Circ Res 88, 325-333.
29. 2α-induced contraction of rabbit aortae. J Physiol 546, 823-836.
30. 2+ channel blocker LOE 908. Br J Pharmacol 126, 1107-1114.
31. Janssen LJ, Lu-Chao H & Netherton S (2001). Excitation-contraction coupling in pulmonary vascular smooth muscle involves tyrosine kinase and Rho kinase. Am J Physiol 280, L666-L674.
32. Jernigan NL, Broughton BR, Walker BR & Resta TC (2006). Impaired NO-dependent inhibition of store- and receptor-operated calcium entry in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol (in press DOI:).
33. 2+. J Biol Chem 264, 5339-5342.
34. 2+-free media are mediated by different signal transduction pathways in rat aorta. Br J Pharmacol 110, 875-881.
35. 2+-permeable nonselective cation channels in vascular smooth muscle: A physiologic perspective. J Cardiovasc Electrophysiol 13, 493-501.
36. Leach RM, Twort CH, Cameron IR & Ward JP (1992). A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat. Clin Sci (Lond) 82, 55-62.
37. 2+ channels. Science 287, 1647-1651.
38. 2+ handling of human small arteries. Am J Physiol 279, H1228-H1238.
39. 2+ entry in A7r5 vascular smooth muscle cells: Only the latter operates during receptor activation. Biochem J 362, 13-21.
40. Narumiya S, Sugimoto Y & Ushikubi F (1999). Prostanoid receptors: structures, properties, and functions. Physiol Rev 79, 1193-1226.
41. 2. Circ Res 88, 1283-1290.
42. 2+ spark discharge region in isolated smooth muscle cells from guinea-pig mesenteric arteries. Cell Calcium (in press, DOI:)
43. Robertson TP, Hague D, Aaronson PI & Ward JP (2000). Voltage-independent calcium entry in hypoxic pulmonary vasoconstriction of intrapulmonary arteries of the rat. J Physiol 525, 669-680.
44. 2α), in some isolated smooth muscle preparations. Br J Pharmacol 130, 1903-1910.
45. Snetkov VA, Aaronson PI, Ward JP, Knock GA & Robertson TP (2003). Capacitative calcium entry as a pulmonary specific vasoconstrictor mechanism in small muscular arteries of the rat. Br J Pharmacol 140, 97-106.
46. Takeuchi H, Tanabe M, Okamoto H & Yamazaki M (1999). Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm. Neurol Res 21, 513-516.
47. 2+ entry. Cardiovasc Res 68, 56-64.
48. 2 receptor-mediated contraction in rat aorta. J Pharmacol Exp Ther 284, 921-928.
49. 1- and TP-receptors involved in the contraction of human pulmonary veins. Br J Pharmacol 134, 1671-1678.
50. Ward JP & Snetkov VA (2004). Determination of signaling pathways responsible for hypoxic pulmonary vasoconstriction: Use of the small vessel myograph. Meth Enzymol 381, 71-87.
51. Zamora CA, Baron DA & Heffner JE (1993). Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury. J Appl Physiol 74, 224-229.